Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114


Optimal isolation of functional Foxp3+ induced regulatory T cells using DEREG mice.

Baru AM, Untucht C, Ganesh V, Hesse C, Mayer CT, Sparwasser T.

PLoS One. 2012;7(9):e44760. doi: 10.1371/journal.pone.0044760. Epub 2012 Sep 5.


Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF-β and retinoic acid.

Lu L, Zhou X, Wang J, Zheng SG, Horwitz DA.

PLoS One. 2010 Dec 17;5(12):e15150. doi: 10.1371/journal.pone.0015150.


Limitations of Foxp3(+) Treg depletion following viral infection in DEREG mice.

Christiaansen AF, Boggiatto PM, Varga SM.

J Immunol Methods. 2014 Apr;406:58-65. doi: 10.1016/j.jim.2014.03.005. Epub 2014 Mar 15.


Ex vivo generation of regulatory T cells: characterization and therapeutic evaluation in a model of chronic colitis.

Karlsson F, Robinson-Jackson SA, Gray L, Zhang S, Grisham MB.

Methods Mol Biol. 2011;677:47-61. doi: 10.1007/978-1-60761-869-0_4.


Rapamycin-conditioned donor dendritic cells differentiate CD4CD25Foxp3 T cells in vitro with TGF-beta1 for islet transplantation.

Pothoven KL, Kheradmand T, Yang Q, Houlihan JL, Zhang H, Degutes M, Miller SD, Luo X.

Am J Transplant. 2010 Aug;10(8):1774-84. doi: 10.1111/j.1600-6143.2010.03199.x. Epub 2010 Jul 12.


Peroxisome proliferator-activated receptor α and γ agonists together with TGF-β convert human CD4+CD25- T cells into functional Foxp3+ regulatory T cells.

Lei J, Hasegawa H, Matsumoto T, Yasukawa M.

J Immunol. 2010 Dec 15;185(12):7186-98. doi: 10.4049/jimmunol.1001437. Epub 2010 Nov 5.


Distinct regulatory roles of transforming growth factor-beta and interleukin-4 in the development and maintenance of natural and induced CD4+ CD25+ Foxp3+ regulatory T cells.

Prochazkova J, Fric J, Pokorna K, Neuwirth A, Krulova M, Zajicova A, Holan V.

Immunology. 2009 Sep;128(1 Suppl):e670-8. doi: 10.1111/j.1365-2567.2009.03060.x. Epub 2009 Jan 24.


Nonfunctional regulatory T cells and defective control of Th2 cytokine production in natural scurfy mutant mice.

Lahl K, Mayer CT, Bopp T, Huehn J, Loddenkemper C, Eberl G, Wirnsberger G, Dornmair K, Geffers R, Schmitt E, Buer J, Sparwasser T.

J Immunol. 2009 Nov 1;183(9):5662-72. doi: 10.4049/jimmunol.0803762. Epub 2009 Oct 7.


CD4 blockade directly inhibits mouse and human CD4(+) T cell functions independent of Foxp3(+) Tregs.

Mayer CT, Huntenburg J, Nandan A, Schmitt E, Czeloth N, Sparwasser T.

J Autoimmun. 2013 Dec;47:73-82. doi: 10.1016/j.jaut.2013.08.008. Epub 2013 Sep 19.


CD8+ Foxp3+ T cells share developmental and phenotypic features with classical CD4+ Foxp3+ regulatory T cells but lack potent suppressive activity.

Mayer CT, Floess S, Baru AM, Lahl K, Huehn J, Sparwasser T.

Eur J Immunol. 2011 Mar;41(3):716-25. doi: 10.1002/eji.201040913. Epub 2011 Feb 11.


Natural and inducible Tregs in swine: Helios expression and functional properties.

Käser T, Mair KH, Hammer SE, Gerner W, Saalmüller A.

Dev Comp Immunol. 2015 Apr;49(2):323-31. doi: 10.1016/j.dci.2014.12.005. Epub 2014 Dec 12.


[Proliferation of CD4+ CD25+ regulatory T cells of rat by different cytokines in vitro].

Wang ZH, Zhu JY, Li T, Leng XS.

Zhonghua Yi Xue Za Zhi. 2008 Mar 25;88(12):844-7. Chinese.


Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.

Su H, Ye DQ, Wang BL, Fang XH, Chen J, Wang Q, Li WX, Zhang N.

Br J Dermatol. 2008 Jun;158(6):1197-209. doi: 10.1111/j.1365-2133.2008.08555.x. Epub 2008 Apr 10.


In vivo depletion of FoxP3+ Tregs using the DEREG mouse model.

Lahl K, Sparwasser T.

Methods Mol Biol. 2011;707:157-72. doi: 10.1007/978-1-61737-979-6_10.


Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.

Kang N, Tang L, Li X, Wu D, Li W, Chen X, Cui L, Ba D, He W.

Immunol Lett. 2009 Aug 15;125(2):105-13. doi: 10.1016/j.imlet.2009.06.005. Epub 2009 Jun 17.


Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.

Sobel ES, Brusko TM, Butfiloski EJ, Hou W, Li S, Cuda CM, Abid AN, Reeves WH, Morel L.

Arthritis Res Ther. 2011 Jun 27;13(3):R106. doi: 10.1186/ar3387.


Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.

Huang H, Dawicki W, Zhang X, Town J, Gordon JR.

J Immunol. 2010 Nov 1;185(9):5003-10. doi: 10.4049/jimmunol.0903446. Epub 2010 Sep 24.


Dendritic cells control CD4+CD25+ Treg cell suppressor function in vitro through juxtacrine delivery of IL-2.

Kulhankova K, Rouse T, Nasr ME, Field EH.

PLoS One. 2012;7(9):e43609. doi: 10.1371/journal.pone.0043609. Epub 2012 Sep 12.


Strong impact of CD4+ Foxp3+ regulatory T cells and limited effect of T cell-derived IL-10 on pathogen clearance during Plasmodium yoelii infection.

Abel S, Lückheide N, Westendorf AM, Geffers R, Roers A, Müller W, Sparwasser T, Matuschewski K, Buer J, Hansen W.

J Immunol. 2012 Jun 1;188(11):5467-77. doi: 10.4049/jimmunol.1102223. Epub 2012 Apr 27.

Supplemental Content

Support Center